A new combination is awaiting entry into the Proton pump inhibitor (PPI)+ antacids combination market.

This time, the new entrant is a combination of lansoprazole and precipitated calcium carbonate. Ever since Chong Kun Dang achieved outstanding results in the market, new combinations have been pouring out every year in the market.

With already over 70 products in the market, whether the newly released product may settle in the market is gaining attention.

According to industry sources on the 19th, the lansopr